Literature DB >> 8462367

Prevalence of gallstone disease in Mexico. A necropsy study.

N Méndez-Sánchez1, J Jessurun, G Ponciano-Rodríguez, P Alonso-de-Ruiz, M Uribe, M Hernández-Avila.   

Abstract

The prevalence of gallstone disease in Mexico was investigated by studying a sample of 21,446 necropsies performed at the Department of Pathology of the General Hospital of Mexico City during a 35-year period (1953-1988). For each decade, 1000 necropsy cases were randomly selected. The crude prevalence of gallstone disease was 14.3%, 8.5% for males and 20.4% for females. The age groups ranged from 20 to more than 80 years old; the age-standardized prevalence for males was 5.6% and for females 16.2%. These rates are intermediate between those found in Chile and some African countries, comparable to some European studies, and less than those found in Mexican-Americans. No significant trend in the prevalence of gallstone disease was found when the different decades were compared.

Entities:  

Mesh:

Year:  1993        PMID: 8462367     DOI: 10.1007/bf01316800

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  19 in total

1.  In-vivo and post-mortem gallstones: support for validity of the "epidemiologic necropsy" screening technique.

Authors:  N J Simonovis; C K Wells; A R Feinstein
Journal:  Am J Epidemiol       Date:  1991-05-01       Impact factor: 4.897

Review 2.  The epidemiology of gallstones and suggested aetiology.

Authors:  K W Heaton
Journal:  Clin Gastroenterol       Date:  1973-01

3.  Frequency of cholelithiasis in Prague and Malmö. An autopsy study.

Authors:  A Zahor; N H Sternby; A Kagan; K Uemura; R Vanecek; A M Vichert
Journal:  Scand J Gastroenterol       Date:  1974       Impact factor: 2.423

4.  [Incidence of cholelithiasis in autopsy material and analysis of the composition of calculi].

Authors:  I Marinovic; C Guerra; G Larach
Journal:  Rev Med Chil       Date:  1972-11       Impact factor: 0.553

5.  Changing state of gallstone disease in Japan. Composition of the stones and treatment of the condition.

Authors:  F Nakayama; H Miyake
Journal:  Am J Surg       Date:  1970-12       Impact factor: 2.565

6.  Genetics and epidemiology of gallbladder disease in New World native peoples.

Authors:  K M Weiss; R E Ferrell; C L Hanis; P N Styne
Journal:  Am J Hum Genet       Date:  1984-11       Impact factor: 11.025

7.  Gallbladder disease epidemiology in Mexican Americans in Starr County, Texas.

Authors:  C L Hanis; R E Ferrell; B R Tulloch; W J Schull
Journal:  Am J Epidemiol       Date:  1985-11       Impact factor: 4.897

8.  Morbidity from cancer in La Paz, Bolivia.

Authors:  J Ríos-Dalenz; P Correa; W Haenszel
Journal:  Int J Cancer       Date:  1981-09-15       Impact factor: 7.396

9.  Comparative prevalence of gallstone disease at 100-year interval in a large Romanian town, a necropsy study.

Authors:  M Acalovschi; D Dumitrascu; I Caluser; A Ban
Journal:  Dig Dis Sci       Date:  1987-04       Impact factor: 3.199

10.  The role of behavioral variables and fat patterning in explaining ethnic differences in serum lipids and lipoproteins.

Authors:  S M Haffner; M P Stern; H P Hazuda; M Rosenthal; J A Knapp
Journal:  Am J Epidemiol       Date:  1986-05       Impact factor: 4.897

View more
  14 in total

Review 1.  Cholesterol gallstones: from epidemiology to prevention.

Authors:  M Acalovschi
Journal:  Postgrad Med J       Date:  2001-04       Impact factor: 2.401

2.  Risk factors for gallstone disease in Mexicans are similar to those found in Mexican-Americans.

Authors:  N Méndez-Sánchez; H Vega; M Uribe; L Guevara; M H Ramos; F Vargas-Vorackova
Journal:  Dig Dis Sci       Date:  1998-05       Impact factor: 3.199

3.  Gallstone disease in Peruvian coastal natives and highland migrants.

Authors:  P L Moro; W Checkley; R H Gilman; L Cabrera; A G Lescano; J J Bonilla; B Silva
Journal:  Gut       Date:  2000-04       Impact factor: 23.059

4.  Metabolic syndrome as a risk factor for gallstone disease.

Authors:  Nahum Méndez-Sánchez; Norberto C Chavez-Tapia; Daniel Motola-Kuba; Karla Sanchez-Lara; Guadalupe Ponciano-Rodríguez; Héctor Baptista; Martha H Ramos; Misael Uribe
Journal:  World J Gastroenterol       Date:  2005-03-21       Impact factor: 5.742

5.  Low serum levels of ghrelin are associated with gallstone disease.

Authors:  Nahum Mendez-Sanchez; Guadalupe Ponciano-Rodriguez; Luisa Bermejo-Martinez; Antonio-R Villa; Norberto-C Chavez-Tapia; Daniel Zamora-Valdes; Raul Pichardo-Bahena; Blanca Barredo-Prieto; Martha-H Uribe-Ramos; Martha-H Ramos; Hector A Baptista-Gonzalez; Misael Uribe
Journal:  World J Gastroenterol       Date:  2006-05-21       Impact factor: 5.742

6.  Distribution of the ATP-binding cassette transporter ABCG8 IVS1-2A>G genotype and clinical characteristics of gallbladder patients in Northeastern Mexico: A pilot study.

Authors:  Pamela Frigerio; Ana Cecilia Cepeda-Nieto; Selim Marcos-Morales; Abel Peña-Velázquez; Sergio Dávila-Flores; Mauricio Salinas-Santander
Journal:  Biomed Rep       Date:  2018-07-03

7.  Increasing gallstone prevalence and cholecystectomy rate in a large Romanian town. A necropsy study.

Authors:  M Acalovschi; M Pascu; S Iobagiu; M Petrescu; C D Olinici; A Ban; D Dumitrascu
Journal:  Dig Dis Sci       Date:  1995-12       Impact factor: 3.199

Review 8.  New insights into the molecular mechanisms underlying effects of estrogen on cholesterol gallstone formation.

Authors:  Helen H Wang; Min Liu; Deborah J Clegg; Piero Portincasa; David Q-H Wang
Journal:  Biochim Biophys Acta       Date:  2009-07-06

9.  A 10-year follow-up of a longitudinal study of gallstone prevalence at necropsy in South East England.

Authors:  Hamed N Khan; Margaret Harrison; Eryl E Bassett; Tom Bates
Journal:  Dig Dis Sci       Date:  2009-12       Impact factor: 3.199

10.  Increased prevalence of gallstone disease and impaired gallbladder motility in patients with Barrett's esophagus.

Authors:  Ferenc Izbéki; András I Rosztóczy; John Sebit Yobuta; Richárd Róka; János Lonovics; Tibor Wittmann
Journal:  Dig Dis Sci       Date:  2007-12-14       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.